×
App Icon
The Standard e-Paper
Stay Informed, Even Offline
★★★★ - on Play Store
Read on the App

Pfizer-BioNTech vaccine deliveries could start 'before Christmas'

Pfizer Inc and BioNTech could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no serious side effects, the drugmakers said on Wednesday.

Get Full Access for Ksh299/Week
Fact‑first reporting that puts you at the heart of the newsroom. Subscribe for full access.
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in